Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 4/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.35 |
| ▸ | F10 | P00742 | 1/20 | 0.35 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.35 |
| ▸ | KLKB1 | P03952 | 2/20 | 0.35 |
| ▸ | DHODH | Q02127 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12911546 | 0.95 | NOTUM (0.37) | PDE4BKDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL782368 | 0.94 | CARM1 (0.39) | PDE4BKDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL13072399 | 0.93 | F10 (0.36) | PDE4BKDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL12911536 | 0.93 | PDE4B (0.37) | PDE4BKDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL13072910 | 0.93 | ALDH1A1 (0.39) | PDE4BKDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL13318514 | 0.92 | PDE4B (0.38) | PDE4BKDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL13318527 | 0.92 | F10 (0.37) | PDE4BKDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL12529008 | 0.92 | GRM4 (0.39) | MEN1ALDH1A1MAPTKMT2ATRPV1 | |
| SCHEMBL13318525 | 0.92 | F10 (0.35) | PDE4BKDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL12827704 | 0.92 | CARM1 (0.37) | PDE4BKDM4EMEN1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100137314-A1 | HARMFUL ORGANISM CONTROL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-03 | — | — | US | disclosed |
| US-20100099692-A1 | HARMFUL ORGANISM CONTROL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100099692-A1 | HARMFUL ORGANISM CONTROL COMPOSITION | UQCRC1, UQCRC2, Q6ZSR9 | PDE4B 1981/4885KDM4E 2026/4885MEN1 2791/4885 |
| US-20100137314-A1 | HARMFUL ORGANISM CONTROL COMPOSITION | UQCRC2, UQCRC1, UQCRB | PDE4B 2099/4885KDM4E 2615/4885MEN1 3045/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.